Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THROMBIN: Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients
NCT06051214Recruiting
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Sep 2023
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut Cancérologique de l'Ouest. Primary endpoint: Changes in thrombogram values as predictive of thromboembolic events at 12 months. Started Sep 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06051214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06051214.